Vanguard 500 Index Fund
FundVFINXNASDAQ0.00 n/a
+0.00%(+0.00)
About
The fund employs an indexing investment approach designed to track the performance of the Standard & Poor's 500 Index, a widely recognized benchmark of U.S. stock market performance that is dominated by the stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
Key Facts
Expense Ratio
—
Assets Under Management
—
NAV
—
Holdings
—
Inception Date
—
Asset Class
—
Issuer
—
Avg. Volume
—
Market Cap
$1.70T
Beta
1.00
52-Week Range
$574.70$690.67$703.53
52W LowCurrent52W High
Performance
1 Week
+1.45%
1 Month
−1.70%
3 Months
+14.62%
YTD
+9.29%
1 Year
+20.60%
3 Years
+72.31%
5 Years
+75.87%
Sector Exposure
Sector exposure data isn't available for this fund yet.
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| NVDA | NVIDIA Corp | 7.90% | $134.32B |
| AAPL | Apple Inc | 7.05% | $119.94B |
| MSFT | Microsoft Corp | 5.15% | $87.53B |
| AMZN | Amazon.com Inc | 4.07% | $69.22B |
| GOOGL | Alphabet Inc | 3.41% | $57.97B |
| AVGO | Broadcom Inc | 3.26% | $55.46B |
| GOOG | Alphabet Inc | 2.71% | $46.09B |
| META | Meta Platforms Inc | 2.13% | $36.22B |
| TSLA | Tesla Inc | 1.89% | $32.09B |
| MU | Micron Technology Inc | 1.68% | $28.61B |
| LLY | Eli Lilly & Co | 1.35% | $22.92B |
| BRK-B | Berkshire Hathaway Inc | 1.34% | $22.78B |
| AMD | Advanced Micro Devices Inc | 1.30% | $22.03B |
| JPM | JPMorgan Chase & Co | 1.16% | $19.74B |
| XOM | Exxon Mobil Corp | 0.93% | $15.89B |
| JNJ | Johnson & Johnson | 0.84% | $14.22B |
| INTC | Intel Corp | 0.83% | $14.10B |
| V | Visa Inc | 0.83% | $14.09B |
| WMT | Walmart Inc | 0.78% | $13.28B |
| CSCO | Cisco Systems Inc | 0.73% | $12.46B |
| COST | Costco Wholesale Corp | 0.65% | $11.11B |
| CAT | Caterpillar Inc | 0.63% | $10.67B |
| MA | Mastercard Inc | 0.62% | $10.53B |
| LRCX | Lam Research Corp | 0.61% | $10.40B |
| ABBV | AbbVie Inc | 0.59% | $10.07B |